Nils Kossack

520 total citations
43 papers, 316 citations indexed

About

Nils Kossack is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and General Health Professions. According to data from OpenAlex, Nils Kossack has authored 43 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Epidemiology and 6 papers in General Health Professions. Recurrent topics in Nils Kossack's work include Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Health Promotion and Cardiovascular Prevention (5 papers) and Respiratory Support and Mechanisms (4 papers). Nils Kossack is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Health Promotion and Cardiovascular Prevention (5 papers) and Respiratory Support and Mechanisms (4 papers). Nils Kossack collaborates with scholars based in Germany, United Kingdom and United States. Nils Kossack's co-authors include Marc Pignot, Dennis Häckl, Sonja Ständer, Sylvie Gabriel, Rajeev Chavda, Claus Vogelmeier, Felix W. Friedrich, Tonio Schoenfelder, Peter Hammerer and Axel S. Merseburger and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Nils Kossack

34 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nils Kossack Germany 11 110 72 61 35 32 43 316
Mandeep Singh Rahi United States 7 104 0.9× 48 0.7× 15 0.2× 11 0.3× 29 0.9× 24 268
Ercan Türkmen Türkiye 9 90 0.8× 33 0.5× 20 0.3× 12 0.3× 26 0.8× 32 314
Stephanie Korrer United States 11 88 0.8× 30 0.4× 34 0.6× 14 0.4× 99 3.1× 22 310
José Manuel Rodríguez Spain 12 57 0.5× 56 0.8× 62 1.0× 16 0.5× 12 0.4× 35 382
Nurol Arık Türkiye 13 112 1.0× 49 0.7× 15 0.2× 12 0.3× 20 0.6× 31 411
Erden Goljo United States 9 86 0.8× 36 0.5× 44 0.7× 4 0.1× 19 0.6× 14 358
Amik Sodhi United States 8 74 0.7× 56 0.8× 12 0.2× 6 0.2× 33 1.0× 20 322
Dênis Szejnfeld Brazil 12 77 0.7× 141 2.0× 112 1.8× 6 0.2× 47 1.5× 45 481
Stamatis Katsenos Greece 12 240 2.2× 121 1.7× 10 0.2× 6 0.2× 47 1.5× 45 421
Abut Kebudi Türkiye 12 83 0.8× 16 0.2× 27 0.4× 20 0.6× 14 0.4× 37 335

Countries citing papers authored by Nils Kossack

Since Specialization
Citations

This map shows the geographic impact of Nils Kossack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Kossack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Kossack more than expected).

Fields of papers citing papers by Nils Kossack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Kossack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Kossack. The network helps show where Nils Kossack may publish in the future.

Co-authorship network of co-authors of Nils Kossack

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Kossack. A scholar is included among the top collaborators of Nils Kossack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Kossack. Nils Kossack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyer, Anna C., Inka Albrecht, Nils Kossack, et al.. (2025). Clinical and Economic Burden of COPD in Patients on Inhaled Triple Therapy in Germany – A Retrospective Claims Data Analysis. International Journal of COPD. Volume 20. 3893–3906.
2.
Vogelmeier, Claus, et al.. (2025). Comorbidities and Cause of Death in COPD Patients Compared to Non-COPD Controls: An 8-year Observational Retrospective Healthcare Claims Database Cohort Study. International Journal of COPD. Volume 20. 2117–2130. 1 indexed citations
4.
Seitz, Lisa, et al.. (2024). MSR162 Identification of Patients With Obesity, Based on Their Comorbidities. Value in Health. 27(12). S470–S470. 1 indexed citations
5.
Vogelmeier, Claus, Kai Michael Beeh, Nils Kossack, et al.. (2024). Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. International Journal of COPD. Volume 19. 1835–1848. 3 indexed citations
6.
Brestrich, Gordon, et al.. (2024). Excess Healthcare Costs and Resource Utilisation of Lyme Borreliosis in Germany: A Propensity Score–Matched Cohort Study. Zoonoses and Public Health. 72(1). 23–31. 3 indexed citations
7.
Brestrich, Gordon, Nils Kossack, James H. Stark, et al.. (2024). Incidence of Lyme Borreliosis in Germany: A retrospective observational healthcare claims study. Ticks and Tick-borne Diseases. 15(3). 102326–102326. 9 indexed citations
10.
Pignot, Marc, et al.. (2023). RWD133 Cross Sectional Claims Data Analysis on Myopia Epidemiology and Treatment Options in Germany. Value in Health. 26(12). S529–S529. 1 indexed citations
11.
Rothnie, Kieran, Stephen G. Noorduyn, Jonathan C. Claussen, et al.. (2023). PCR255 Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions. Value in Health. 26(12). S499–S499. 1 indexed citations
12.
Vogelmeier, Claus, et al.. (2023). Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study. Respiratory Medicine. 222. 107506–107506. 12 indexed citations
13.
Ständer, Sonja, et al.. (2023). Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real‐world evidence claims data study. Journal of the European Academy of Dermatology and Venereology. 38(5). 883–894. 7 indexed citations
15.
Hartmann, Bojan, Paul Balfanz, Niels‐Ulrik Korbinian Hartmann, et al.. (2022). Glycaemic variability is associated with all-cause mortality in COVID-19 patients with ARDS, a retrospective subcohort study. Scientific Reports. 12(1). 9862–9862. 8 indexed citations
16.
O’Kelly, James, et al.. (2022). Real-world effectiveness of osteoporosis treatments in Germany. Archives of Osteoporosis. 17(1). 119–119. 13 indexed citations
17.
Balfanz, Paul, Bojan Hartmann, Dirk Müller‐Wieland, et al.. (2021). Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19. PLoS ONE. 16(1). e0246182–e0246182. 10 indexed citations
18.
Ständer, Sonja, et al.. (2020). Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis. Acta Dermato Venereologica. 100(18). adv00309–adv00309. 54 indexed citations
19.
O’Kelly, James, et al.. (2020). PMS3 Real-World Effectiveness of Osteoporosis Treatments in Germany. Value in Health. 23. S592–S592. 1 indexed citations
20.
Weinhold, Ines, et al.. (2019). Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany?. The European Journal of Health Economics. 20(8). 1181–1193. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026